Nicox SA (NICXF)
0.44
0.00 (0.00%)
USD |
OTCM |
May 17, 16:00
Nicox Shareholders Equity (Quarterly): 23.67M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 23.67M |
| June 30, 2023 | 49.48M |
| June 30, 2023 | 49.48M |
| December 31, 2022 | 45.36M |
| June 30, 2022 | 63.41M |
| June 30, 2022 | 63.41M |
| December 31, 2021 | 85.54M |
| June 30, 2021 | 108.67M |
| June 30, 2021 | 108.67M |
| December 31, 2020 | 124.02M |
| June 30, 2020 | 107.47M |
| June 30, 2020 | 107.47M |
| December 31, 2019 | 122.43M |
| June 30, 2019 | 130.10M |
| June 30, 2019 | 130.10M |
| December 31, 2018 | 130.01M |
| June 30, 2018 | 141.34M |
| June 30, 2018 | 141.34M |
| December 31, 2017 | 152.08M |
| June 30, 2017 | 111.34M |
| June 30, 2017 | 111.34M |
| December 31, 2016 | 110.52M |
| June 30, 2016 | 87.46M |
| Date | Value |
|---|---|
| June 30, 2016 | 87.46M |
| December 31, 2015 | 110.79M |
| June 30, 2015 | 133.72M |
| June 30, 2015 | 133.72M |
| December 31, 2014 | 117.08M |
| June 30, 2014 | 64.70M |
| June 30, 2014 | 64.70M |
| December 31, 2013 | 84.76M |
| September 30, 2013 | 83.66M |
| June 30, 2013 | 85.92M |
| March 31, 2013 | 90.12M |
| December 31, 2012 | 98.60M |
| September 30, 2012 | 103.28M |
| June 30, 2012 | 104.67M |
| March 31, 2012 | 117.87M |
| December 31, 2011 | 109.22M |
| September 30, 2011 | 123.17M |
| June 30, 2011 | 135.06M |
| March 31, 2011 | 136.20M |
| December 31, 2010 | 133.64M |
| September 30, 2010 | 142.58M |
| June 30, 2010 | 143.74M |
| March 31, 2010 | 184.83M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
23.67M
Minimum
Dec 2023
130.10M
Maximum
Jun 2019
87.95M
Average
107.47M
Median
Jun 2020
Shareholders Equity (Quarterly) Benchmarks
| DBV Technologies SA | 111.65M |
| Cellectis SA | 84.70M |
| PHAXIAM Therapeutics SA (DELISTED) | -- |
| Genfit SA | 75.11M |
| Innate Pharma SA | 57.37M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 58.56M |
| Total Liabilities (Quarterly) | 34.89M |
| Debt to Equity Ratio | 1.175 |
| Current Ratio | 8.967 |
| Net Debt Paydown Yield | -9.48% |